Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Exercise hormone can prevent Alzheimer’s finds study

Exercise hormone can prevent Alzheimer’s finds study

According to a large worldwide study, the hormone that is produced in the body during exercise called irisin, can prevent and delay the onset of mental faculty decline and Alzheimer’s disease. The results of the study were published in the latest issue of the journal Nature Medicine.

Irisin, a cleaved version of FNDC5. Promotes conversion of white fat tissue to brown. Image Credit: ibreakstock / Shutterstock

Irisin, a cleaved version of FNDC5. Promotes conversion of white fat tissue to brown. Image Credit: ibreakstock / Shutterstock

Irisin is produced within the muscles during intense exercise and physical activity. It was six years back and was found to be instrumental in burning fat. Irisin has been on the cards for obesity researchers worldwide for its potential to help reduce fat. In these latest studies on mice and humans, researchers have found that irisin helps protect against mental decline that is commonly seen with aging process. This study by Fernana de Felice at the Federal University of Rio de Janerio and colleagues, proves the adage the regular exercise keeps the body as well as mind healthy.

Neurobiologist Professor Ottavio Arancio, from the Columbia University and this study’s lead researcher said, “Irisin could comprise an attractive novel therapy aimed to prevent dementia in patients at risk.” He said that irisin can delay the “progression in patients at the later stages – including those who can no longer exercise.” He explained, “Many patients with dementia are disabled due to other age-related conditions or co-morbidities – for example arthritis, heart disease, obesity, visual problems, depression – that preclude them from engaging in regular physical exercise. Therefore, the development of alternative approaches that build on the beneficial effects of exercise in the brain may benefit those patients.”

In this study the team studied a gene called the FNDC5. This gene regulates the formation of irisin. They switched off this gene in the lab mice. This effectively stopped the production of irisin. These animals showed problems of learning and memory progressively, they noted. The switched on the FNDC5 gene in the mice to see that the brain cells had restored function. The team also studied brain tissues and blood and spinal fluids of people who had died of dementia. They compared this with blood samples and spinal fluid samples of living healthy matches who did not have dementia. The team found that patients with Alzheimer’s gradually lose the synapses of connections of the brain and this causes loss of memory. Irisin is found to restore these synapses.

According to Dr James Pickett, head of research at Alzheimer’s Society, “Although this study was only in mice, it adds to mounting evidence of the relationship between lifestyle factors, like physical fitness, and dementia. This is a promising avenue for more research and potentially new therapies in future. We know that exercise can decrease a person’s risk of developing dementia, but still have lots to learn about its effect on cognitive decline – for example, we need to know how this hormone gets into the brain, how it works, whether it is effective in people, and whether it affects men and women in the same way – which is why we’re funding a long-term study of 700 middle-aged people at risk of dementia to better understand these links.” He explained that there have been no new drugs for dementia in the last one and half decades and this study can show a new avenue of research in tackling dementia and Alzheimer’s disease. “We know that exercise not only helps people with dementia to manage certain side-effects but also reduces the risk of developing the condition, which gives us all more motivation for those New Year’s Resolutions to get fit and healthy,” he said. Rosa Sancho at the charity Alzheimer’s Research UK added, “We know that physical activity is linked to better brain health as we age, and this research highlights a biological mechanism that may contribute to this beneficial effect.” At present 35 million people worldwide who are suffering from age related dementia and Alzheimer’s disease.

Prof Arancio said, “Defective brain hormonal signalling has been associated with Alzheimer’s disease, a disorder characterised by synapse and memory failure. By showing irisin is an important mediator of the beneficial effects of exercise in Alzheimer’s disease models our findings place it as a novel agent capable of opposing synapse failure and memory impairment.” He added, “Bolstering brain irisin levels – either pharmacologically or through exercise – may thus constitute a novel therapeutic strategy to protect and repair synapse function and prevent cognitive decline in Alzheimer’s disease.”

Source:

https://www.nature.com/articles/s41591-018-0275-4

Tagged with:

About author

Related Articles